ZyVersa Therapeutics, Inc. short interest in 2025
In 2025, ZyVersa Therapeutics, Inc.'s disclosed short interest ran from 1.89% of shares outstanding on 28 Feb 2025 to 20.13% on 15 Jul 2025, a change of +18.24 percentage points. The year's high was 20.13% on 15 Jul 2025 and its low 1.89% on 28 Feb 2025, averaging 9.71% across 7 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.57 days on 31 Mar 2025. Full history: ZyVersa Therapeutics, Inc..
Cite this page
2025 in figures
- Start of year
- 1.89% (28 Feb 2025)
- End of year
- 20.13% (15 Jul 2025)
- Change
- +18.24 pp
- High
- 20.13% (15 Jul 2025)
- Low
- 1.89% (28 Feb 2025)
- Average
- 9.71%
- Highest days to cover
- 1.57 (31 Mar 2025)
- SEC filings marked
- 5
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 28 Feb 2025 | 1.89% | 1.00 | |
| 31 Mar 2025 | 4.27% | 1.57 | 10-K filed |
| 15 May 2025 | 8.63% | 1.00 | 10-Q filed |
| 30 May 2025 | 11.72% | 1.00 | |
| 13 Jun 2025 | 7.36% | 1.00 | |
| 30 Jun 2025 | 13.99% | 1.00 | |
| 15 Jul 2025 | 20.13% | 1.00 |
See also: ZyVersa Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.